The trademark LeadPharma was filed by Lead Pharma Holding B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on May 16, 2021, and received one opposition filed on August 16, 2021 by BIOMEDICA DIVISION HOSPITALARIA, S.L.L. on (a) Identity of marks and Goods and Services, (b) Likelihood of confusion. the opponent was represented by LEGISMARK and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued August 16, 2021
It was designated 'Basic Application' for International Application 1610159 at the World Intellectual Property Organization (WIPO).
The application was filed in Dutch, and Dutch was also language of all opposition proceedings (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations and pharmaceutical products
Pharmaceutical preparations and pharmaceutical products for the treatment and prevention of autoimmune diseases, cancer, metabolic diseases, cardiological diseases, haematological diseases, diabetes, urological diseases, eye diseases, osteoporosis, depression, mental illness, bone diseases, respiratory diseases, asthma, kidney diseases, gastrointestinal diseases
All the above-mentioned goods, excluding hygienic products for medical purposes, dietetic substances for medical use, foods for babies, plasters, materials for dressings, essences of dill or turpentine for medical use, glycerin, gums, balms, cold creams for medical use and tooth filling material, disinfectants, soaps for medical use.
The mark was filed in class 42 with following description of goods:
Research and development in the field of pharmaceuticals and medicines
Pharmaceutical research and drug research advisory services
Providing information on medical and scientific research in the field of pharmaceutical substances and clinical trials.